NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ahram Biosystems

Ahram Biosystems

Private
SeoulHealthcare & Life Scienceshttp://ahrambio.com/

Last Round

M&A

May 14, 2020

Total Funding Raised

$11.57M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ahram Biosystems is a diagnostic equipment company that develops life science tools designed to bring portable technology to the biotechnology market, including PCR devices and cell-based assay systems.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

portable PCRhandheld PCRrapid PCRreal-time PCRqPCRmolecular diagnosticspoint-of-care testingPOCTPCRthermal cyclernucleic acid amplificationin-field testingbiotech equipmentPCR reagentsenvironmental testingfood safety testingforensics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ahram Biosystems Comparables

Compare Ahram Biosystems with similar companies based on industry and business-model similarity.

Ahram Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Ahram Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AMay 14, 2020
GrantOct 16, 2017
Series BMar 9, 2017
GrantNov 11, 2015
Early FundingMar 24, 2015

Ahram Biosystems Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 35% MoM, reaching 2.1K.

  • Jan 23, 2026

    Monthly visitors grew 67% MoM, reaching 1.8K.

Ahram Biosystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ahram Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ahram Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range9
Year Founded2001
Last FundingMay 14, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.